IDEX Biometrics Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de IDEX Biometrics.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Electronic	8.7%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como IDEX Biometrics no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

LSE:0MTP - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
6/30/2024	2	-24	-23	-23	N/A
3/31/2024	3	-25	-25	-25	N/A
12/31/2023	4	-27	-27	-27	N/A
9/30/2023	5	-28	-30	-30	N/A
6/30/2023	5	-30	-30	-30	N/A
3/31/2023	4	-32	-32	-32	N/A
12/31/2022	4	-33	-32	-31	N/A
9/30/2022	4	-37	-33	-32	N/A
6/30/2022	4	-35	-32	-31	N/A
3/31/2022	3	-33	-29	-29	N/A
12/31/2021	3	-33	-28	-28	N/A
9/30/2021	3	-29	-27	-26	N/A
6/30/2021	2	-29	-26	-26	N/A
3/31/2021	2	-28	-25	-25	N/A
12/31/2020	1	-27	-24	-23	N/A
9/30/2020	1	-29	-23	-23	N/A
6/30/2020	0	-30	-24	-23	N/A
3/31/2020	0	-31	-25	-24	N/A
12/31/2019	0	-32	-28	-27	N/A
9/30/2019	0	-30	-28	-27	N/A
6/30/2019	0	-30	-28	-27	N/A
3/31/2019	0	-30	-27	-26	N/A
12/31/2018	0	-30	-28	-27	N/A
9/30/2018	1	-30	-28	-27	N/A
6/30/2018	1	-31	-29	-28	N/A
3/31/2018	2	-32	N/A	-33	N/A
12/31/2017	2	-31	N/A	-29	N/A
9/30/2017	3	-30	N/A	-29	N/A
6/30/2017	4	-28	N/A	-25	N/A
3/31/2017	5	-24	N/A	-22	N/A
12/31/2016	4	-24	N/A	-27	N/A
9/30/2016	3	-29	N/A	-28	N/A
6/30/2016	2	-27	N/A	-30	N/A
3/31/2016	0	-28	N/A	-26	N/A
12/31/2015	0	-26	N/A	-21	N/A
9/30/2015	0	-23	N/A	-19	N/A
6/30/2015	0	-21	N/A	-16	N/A
3/31/2015	0	-18	N/A	-19	N/A
12/31/2014	0	-16	N/A	-14	N/A
9/30/2014	0	-16	N/A	-17	N/A
6/30/2014	0	-16	N/A	-13	N/A
3/31/2014	0	-14	N/A	-6	N/A
12/31/2013	0	-11	N/A	-6	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de 0MTP es superior a la tasa de ahorro (1.9%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de 0MTP crezcan más rápidamente que el mercado UK

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de 0MTP crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de 0MTP crezcan más rápidamente que el mercado de UK.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de 0MTP crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de 0MTP se prevé que sea elevada dentro de 3 años.

IDEX Biometrics Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Forecast to breakeven in 2024

IDEX Biometrics ASA Provides Revenue Guidance for the Second Half of 2022

Forecast to breakeven in 2024

No longer forecast to breakeven

IDEX Biometrics ASA Provides Revenue Guidance for the Fourth Quarter of 2021

Recent updates

IDEX Biometrics ASA Introduces Biometric Payment Cards in India

IDEX Biometrics ASA Announces Chief Executive Officer Changes

IDEX Biometrics Appoints Catharina Eklof as the New Chief Executive Officer

IDEX Biometrics Appoints Catharina Eklof as the New Chief Executive Officer

IDEX Biometrics ASA has withdrawn its Follow-on Equity Offering in the amount of NOK 13.2 million.

IDEX Biometrics ASA Appoints Morten Opstad as Chair

IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 55 million.

IDEX Biometrics ASA has filed a Follow-on Equity Offering.

IDEX Biometrics ASA, Annual General Meeting, May 16, 2024

IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 35 million.

IDEX Biometrics ASA announced that it expects to receive NOK 100 million in funding

IDEX Biometrics ASA Announces Chief Financial Officer Changes

IDEX Biometrics Payment Card Solution Fully Certified by Mastercard

IDEX Biometrics Announces Intention to Voluntary Delist of American Depositary Shares from the Nasdaq Capital Market

IDEX Biometrics ASA announced that it expects to receive NOK 150 million in funding

IDEX Biometrics ASA Approves the Election of Adriana Saitta as Board Member

First quarter 2023 earnings released: US$0.01 loss per share (vs US$0.008 loss in 1Q 2022)

IDEX Biometrics Launches a Complete Biometric Payment Card Solution Leveraging Products and Technologies from STMicroelectronics

Full year 2022 earnings released: US$0.03 loss per share (vs US$0.035 loss in FY 2021)

IDEX Biometrics ASA, Annual General Meeting, May 11, 2023

Third quarter 2022 earnings released: US$0.009 loss per share (vs US$0.008 loss in 3Q 2021)

Third quarter 2022 earnings released: US$0.01 loss per share (vs US$0.008 loss in 3Q 2021)

Forecast to breakeven in 2024

IDEX Biometrics ASA Provides Revenue Guidance for the Second Half of 2022

Second quarter 2022 earnings released: US$0.01 loss per share (vs US$0.008 loss in 2Q 2021)

IDEX Biometrics Announces CFO Transition, Effective August 15, 2022

First quarter 2022 earnings released: US$0.01 loss per share (vs US$0.009 loss in 1Q 2021)

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Forecast to breakeven in 2024

Third quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 3Q 2020)

Second quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 2Q 2020)

IDEX Biometrics ASA Biometrics Announces Trustedbio Max

No longer forecast to breakeven

First quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 1Q 2020)

IDEX Biometrics ASA Provides Revenue Guidance for the Fourth Quarter of 2021

Advisor has left the company

Full year 2020 earnings released: US$0.035 loss per share (vs US$0.054 loss in FY 2019)

IDEX Biometrics Further Strengthens its Supply Chain by Partnering with MFLEX

Chief Executive Officer recently bought kr37m worth of stock

Full year 2020 earnings released: US$0.03 loss per share (vs US$0.055 loss in FY 2019)

Revenue misses expectations

Postal Savings Bank of China Launches Idex's Fingerprint Sensors and Biometric Software Have Been Included in Digital RMB

China UnionPay Awards Second LOA to Biometric Payment Card Featuring IDEX Biometrics’ Fingerprint Sensor & Biometric Technology

IDEX Biometrics ASA Expands Partnership with Global Payment Solutions Provider to Include Joint Marketing and Sales

IDEX Biometrics ASA & Tongxin Microelectronics’ Co., Ltd Collaboration Achieves Second China UnionPay Certification

IDEX Biometrics ASA Expands its Strategic Partnerships by Adding Another Global Payment Network

IDEX Biometrics ASA and Partner Goldpac Group Limited Achieve China Union Pay Certification for Dual Interface Biometric Payment Cards

IDEX Biometrics ASA to Report Q1, 2021 Results on May 13, 2021

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento